Upgrade to SI Premium - Free Trial

Wells Fargo on Neurocrine Bio. (NBIX): 'Defending NBIX, We Would Be Buyers Here'

July 31, 2026 11:35 AM
Wells Fargo analyst Mohit Bansal reiterated an Overweight rating and $200.00 price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Trader Talk